Introducing the XPER Research Referral Program

Strong partnerships are often the catalyst for meaningful progress. To strengthen these connections and reward those who help expand our network, we’ve launched a structured and transparent Referral Program designed to create genuine win win outcomes for everyone involved.

To work or not to work with a CRO – That is the Question

For medical device companies, choosing whether to outsource to a CRO is a strategic decision. The “right answer” depends on your stage, device type, regulatory markets, internal capabilities, budget and speed-to-market ambitions.

XPER announces partnership with lifetech.brussels

XPER is proud to announce its new partnership with lifetech.brussels, a leading accelerator for digital health, medtech and life sciences innovation in the Brussels region. By becoming a partner of lifetech.brussels, XPER will work closely with start-ups and scale-ups seeking guidance on how to design, prepare, and execute clinical strategies that set the foundation for successful […]

A Quick Guide to Clinical Investigations under the EU MDR

This blog post provides an overview of the different types of clinical investigations as defined by the MDR, providing a comprehensive overview of each category.

6 Reasons to Conduct your Clinical Trial in Europe

For years, the trend has been “US-first” for medical device clinical studies. However, it’s worth taking a fresh look at Europe as a valuable clinical development location. And here’s why.

XPER Research Acquires Medical and Regulatory Writing Company Lorentis

The acquisition of Lorentis reinforces XPER’s commitment to become the go-to boutique CRO for the MedTech and IVD sector across the globe.

XPER Research Expands Leadership Team

XPER Research welcomes three new managing partners, strengthening its leadership and reinforcing its position as a leading boutique MedTech CRO.